Selected mechanisms of molecular resistance of Candida albicans to azole drugs
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
A phenomenon of increasing resistance of Candida spp. to azoles has been observed for several years now. One of the mechanisms of lack of sensitivity to azoles is associated with CDR1, CDR2, MRD1 genes (their products are active transport pumps conditioning drug efflux from pathogen's cell), and ERG11 gene (encoding lanosterol 14α-demethylase). Test material was 120 strains of Candida albicans (60 resistant and 60 susceptible to azole drugs) obtained from clinical samples. The first stage of experiment assessed the expression of CDR1, CDR2, MDR1 and ERG11 genes by Q-PCR. The impact of ERG11 gene's mutations on the expression of this gene was analysed. The final stage of the experiment assessed the level of genome methylation of Candida albicans strains. An increase in the expression of CDR2, MDR1 and ERG11 was observed in azole-resistant strains of Candida albicans in comparison to strains sensitive to this class of drugs. Furthermore, 19 changes in the sequence of ERG11 were detected in tested strains. Four of the discovered mutations: T495A, A530C, G622A and A945C led to the following amino acid substitutions: D116E, K128T, V159I and E266D, respectively. It has also been found that statistically five mutations: T462C, G1309A, C216T, C1257T and A945C affected the expression of ERG11. The applied method of assessing the level of methylation of Candida albicans genome did not confirm its role in the development of resistance to azoles. The results indicate however, that resistance of Candida albicans strains to azole drugs is multifactorial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, mutations in this pathway, causing alterations in enzymes activity or drug binding sites, are major factors which are related with azole resistance.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations in the ERG11 and ERG3 genes or the UPC2 gene which encodes a transcription factor contribute to azole resistance.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 3×
“According to the literature the following molecular mechanisms of drug resistance can be distinguished: modification of the drug target affinity, overproduction of enzymes that are targets to drugs, development of alternative metabolic pathways, active efflux of drugs from the cell, impermeability of the cell membrane…”
BackgroundInfluentialClinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundEpidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610 · cited 2×
“…Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida kru- sei, Candida guilliermondii, Candida lusitaniae, Candida dubliniensis, Candida pelliculosa, Candida kefyr, Candida lipolytica, Candida famata, Candida inconspicua, Candida rugosa and Candida norvegensis (Yapar, 2014).”
BackgroundComplete inventory of the yeast ABC proteins
Decottignies, A., & Goffeau, A. (1997) · Nature Genetics · doi:10.1038/ng0297-137 · Cited by 454 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundFungal Transporters Involved in Efflux of Natural Toxic Compounds and Fungicides
Del Sorbo, G., Schoonbeek, H.-J., & De Waard, M. A. (2000) · Fungal Genetics and Biology · doi:10.1006/fgbi.2000.1206 · Cited by 357 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundRegulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 2×
“According to the literature the following molecular mechanisms of drug resistance can be distinguished: modification of the drug target affinity, overproduction of enzymes that are targets to drugs, development of alternative metabolic pathways, active efflux of drugs from the cell, impermeability of the cell membrane…”
BackgroundInfluentialImpact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence
de Waard, M. A., Andrade, A. C., Hayashi, K., Schoonbeek, H., Stergiopoulos, I., & Zwiers, L. (2006) · Pest Management Science · doi:10.1002/ps.1150 · Cited by 209 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundChau, A. S., Mendrick, C. A., Sabatelli, F. J., Loebenberg, D., & McNicholas, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2124-2131.2004 · Cited by 187 · cited 1×
“It is worth emphasizing that the expression was studied using the Relative Quantitation software (RQ) for larger group of strains in comparison to studies by other authors (Chau et al., 2004; Cernicka & Subik, 2006; Goldman et al. 2004; Chen et al. 2010).”
ResultCandida and invasive candidiasis: back to basics
Lim, C. S. Y., Rosli, R., Seow, H. F., & Chong, P. P. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1273-3 · Cited by 170 · cited 3×
“These are mainly opportunistic microorganisms belonging to saprophytic flora inhabiting the gastrointestinal tract, urogenital system, skin, and mucous membranes of the airways (Lim et al., 2012).”
BackgroundPathogenicity and drug resistance in Candida albicans and other yeast species
Mishra, N., Prasad, T., Sharma, N., Payasi, A., Prasad, R., Gupta, D., & Singh, R. (2007) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.54.2007.3.1 · Cited by 168 · cited 2×
“According to the literature the following molecular mechanisms of drug resistance can be distinguished: modification of the drug target affinity, overproduction of enzymes that are targets to drugs, development of alternative metabolic pathways, active efflux of drugs from the cell, impermeability of the cell membrane…”
BackgroundInfluentialGoldman, G. H., Ferreira, M. E. D. S., Marques, E. D. R., Savoldi, M., Perlin, D. S., Park, S., Godoy-Martinez, P. C., Goldman, M. H. S., & Colombo, A. L. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.04.009 · Cited by 141 · cited 1×
“It is worth emphasizing that the expression was studied using the Relative Quantitation software (RQ) for larger group of strains in comparison to studies by other authors (Chau et al., 2004; Cernicka & Subik, 2006; Goldman et al. 2004; Chen et al. 2010).”
ResultXu, Y., Chen, L., & Li, C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn015 · Cited by 104
Neppelenbroek, K., Seó, R., Urban, V., Silva, S., Dovigo, L., Jorge, J., & Campanha, N. (2014) · Oral Diseases · doi:10.1111/odi.12123 · Cited by 100 · cited 2×
“Candida spp. are eukaryotic representatives of the fungi kingdom (Lim et al., 2012), which groups about 150–200 species (Neppelenbroek et al., 2014).”
BackgroundClinical relevance of mechanisms of antifungal drug resistance in yeasts
Sanglard, D. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72842-5 · Cited by 98 · cited 1×
“One of the mechanisms of resistance to azole drugs may result from over-expression of CDR1, CDR2 and MDR1 genes, whose products are active transport pumps conditioning drug efflux from the pathogen’s cell (Sanglard, 2002).”
BackgroundFerreira, A. V., Prado, C. G., de Carvalho, R. R., Dias, K. S. T., & Dias, A. L. T. (2013) · Mycopathologia · doi:10.1007/s11046-013-9638-z · Cited by 96 · cited 1×
“Candida albicans is the most thoroughly investigated species and at the same time, the most frequent infection agent among fungi of the Candida genus (Ferreira et al., 2013; Vázquez-González et al., 2013).”
BackgroundResistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis
Cernicka, J., & Šubík, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.12.005 · Cited by 86 · cited 1×
“It is worth emphasizing that the expression was studied using the Relative Quantitation software (RQ) for larger group of strains in comparison to studies by other authors (Chau et al., 2004; Cernicka & Subik, 2006; Goldman et al. 2004; Chen et al. 2010).”
ResultDNA methylation regulates phenotype-dependent transcriptional activity in Candida albicans
Mishra, P. K., Baum, M., & Carbon, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109631108 · Cited by 84 · cited 3×
“Although the applied method of assessing the level of Candida albicans genome methylation has not revealed its role in the development of resistance to azoles, it showed similar level of methylation, suggested by other authors (Mishra et al., 2011).”
BackgroundResultInfluentialOpportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis
Vázquez‐González, D., Perusquía‐Ortiz, A. M., Hundeiker, M., & Bonifáz, A. (2013) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12097 · Cited by 69 · cited 1×
“Candida albicans is the most thoroughly investigated species and at the same time, the most frequent infection agent among fungi of the Candida genus (Ferreira et al., 2013; Vázquez-González et al., 2013).”
BackgroundChen, L., Xu, Y., Zhou, C., Zhao, J., Li, C., & Wang, R. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800216 · Cited by 66 · cited 1×
“It is worth emphasizing that the expression was studied using the Relative Quantitation software (RQ) for larger group of strains in comparison to studies by other authors (Chau et al., 2004; Cernicka & Subik, 2006; Goldman et al. 2004; Chen et al. 2010).”
ResultMorio, F., Pagniez, F., Besse, M., Gay‐Andrieu, F., Miegeville, M., & Pape, P. L. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.07.013 · Cited by 59 · cited 1×
“These mutations can also lead to overexpression of such genes and, subsequently, the overproduction of the enzyme targeted by the drug (Morio et al., 2013).”
BackgroundStrzelczyk, J. K., Ślemp-Migiel, A., Rother, M. B., Gołąbek, K., & Wiczkowski, A. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_2019 · Cited by 22 · cited 2×
“The results of previous studies carried out in the Department of Medical and Molecular Biology, published in Acta Bioch Pol (Strzelczyk et al., 2013) were used to evaluate the effect of selected mutations of ERG11 on its expression.”
MethodSelf-citationPCR in real time. The methods of data analysis
Tyburski, J., Studzinska, A., Daca‐Roszak, P., & Tretyn, A. (2008) · Biotechnologia · Cited by 11
Cited by
de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
Lv, Q.-Z., Yan, L., & Jiang, Y.-Y. (2016) · Virulence · doi:10.1080/21505594.2016.1188236 · Cited by 133
Zieniuk, B., & Fabiszewska, A. U. (2018) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-018-2583-8 · Cited by 106
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans
Liu, S., Yue, L., Gu, W., Li, X., Zhang, L., & Sun, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150859 · Cited by 87
“In order to identify whether the combinations could also reverse one of the most common resistant mechanism of increased drug efflux, we conducted rhodamine 6G assays to investigate activity of efflux pump protein and RT-PCR to determine gene expression of CDR1, CDR2 andMDR1 [28].”
MethodDu, W., Zhai, P., Wang, T., Bromley, M. J., Zhang, Y., & Lu, L. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01839-20 · Cited by 46
Metadata
- Authors
- Gołąbek, K., Strzelczyk, J. K., Owczarek, A., Cuber, P., Ślemp-Migiel, A., & Wiczkowski, A.
- Affiliations
- Medical University of Silesia (PL)
- Laboratory of Microbiology in Hospital in Nowy Targ, Nowy Targ, Poland
- ORCID
- Venue
- Acta Biochimica Polonica
- Publisher
- Frontiers Media SA
- Published
- 2015
- Volume
- 62
- Issue
- 2
- Pages
- 247-251
- ISSN
- 0001-527X (ISSN-L)
- 1734-154X
- OpenAlex
- W2165858950
- Cited by
- 26
- References
- 22
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 2
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Acta Biochimica Polonica (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Uniwersytet Łódzki
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, azole resistance, antifungal resistance, CDR1, CDR2, MDR1, ERG11, lanosterol 14α-demethylase, drug efflux pumps, gene expression, ERG11 mutations, multidrug resistance
- MeSH terms
- Antifungal Agents, Azoles, Candida albicans, Cytochrome P-450 Enzyme System, Fungal Proteins, Humans, Mutation, Gene Expression Regulation, Fungal, DNA Methylation, ATP Binding Cassette Transporter, Subfamily B, Member 1, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.